Drug recall · January 2, 2013
Cymevene 500 mg Powder for Infusion recall
Why: Lack of Assurance of Sterility; container closure issues with the bulk batch.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom
- Lots / codes
bulk lot N0019, Expiration Date: 11 2014 Warennummer: 10131968 Chargennummer:NXXXX 2000609D Finished product Lot N0019B01-N0019B12
- Quantity
- 42010 vials
- Company
- F. Hoffmann-LaRoche Ltd., Basel, N/A
- Distribution
- No product distributed in the USA. Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.
- Initiated
- September 5, 2012 · Voluntary: Firm initiated
- Classified
- December 21, 2012
- Reported
- January 2, 2013
- Ended
- August 29, 2013
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ganciclovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.